Summary: Once diagnosed, the patient was placed on high-risk protocol
chemotherapy for stage IV neuroblastoma; during this treatment, the
patient went into remission. Then, 23 months after diagnosis, he
relapsed with diffuse metastatic disease of the bone marrow. Seven
months later, he was admitted to the hospital with seizures, at
which time extra-axial central nervous system (CNS) metastases were
found (Figure 1). The patient was started on another regimen of
chemotherapy, but in 4 months, he was readmitted to the hospital
for significant mental status changes and left hemiparesis (Figure
2).
Diagnosis
Metastatic neuroblastoma to the CNS with sutural diastasis
Findings
The initial computed tomography (CT) scan showed extra-axial and
calvarial lesions that encased the brain parenchyma of both
cerebral hemispheres, producing some separation of the calvarial
sutures (Figure 1A and B). No intra-axial lesions were identified
at that time, except the right lateral extraconal orbital
involvement (Figure 1C).
Four months later, a follow-up study revealed significant
interval progression of the disease. There was an increase in size
of the extra-axial metastases, with diffuse permeative calvarial
bone destruction and periosteal reaction. The sutures were now
widely separated because of the mass effect of the metastases
(Figure 2A). Additionally, the scan revealed the development of a
large right frontal lobe hematoma, with extension into the
ventricles. Subsequent midline shift with subfalcine herniation was
present (Figure 2B). Further tumor progression was evidenced by
bilateral extraconal orbital extension, causing bilateral proptosis
(Figure 2C).
Discussion
Neuroblastoma is the most common solid abdominal mass in infancy
and the third most common overall malignancy, following leukemia
and CNS tumors in children. The median age of diagnosis is 22
months.
1 Neuroblastomas arise from neural crest tissue
and can thus be found anywhere along the sympathetic chain. The
most common area of involvement is the adrenal gland, where
approximately one third of these tumors are located. The second
most common area is the extra-adrenal retroperitoneum, followed by
the posterior mediastinum.
2 Much less common sites
include the neck and pelvis (organ of Zuckerkandl).
3
Clinical presentation depends on the extent and location of
disease. Most patients present with an abdominal mass, which may be
accompanied by constitutional symptoms of fever, weight loss, and
malaise. Since neuroblastoma has the propensity for increased
catecholamine production, symptoms may include flushing,
hypertension, diaphoresis, tachycardia, intractable diarrhea, and
hyperglycemia. If the tumor invades the neural foramina and
compresses a nerve, peripheral nerve deficits can appear. Orbital
metastatic disease may result in proptosis or ecchymosis.
Additionally, more than half of neuroblastoma patients have osseous
metastatic disease at the time of diagnosis, which can manifest as
Hutchinson syndrome if limping and irritability are
present.1
CT is the most common modality for radiographic assessment of
neuroblastoma. Typical findings include a large, irregularly
shaped, heterogeneous adrenal mass, which often contains areas of
necrosis, hemorrhage, and calcification.3 The tumor has
a tendency to infiltrate around regional structures rather than
displace them.1 Adenopathy and vascular encasement
without actual invasion are also characteristic
findings.1 Other radiographic manifestations of the
disease depend on tumor origin and extent and location of
disease.
Unfortunately, metastatic disease is common in neuroblastoma,
often causing symptoms that prompt medical attention. Common places
for neuroblastoma to metastasize to are cortical bone, bone marrow,
and lymph nodes. In addition, orbital, liver, and skin metastases
are frequently observed, which may lead to proptosis, hepatomegaly,
and dark blue skin masses (also known as "blueberry muffin
syndrome"), respectively. Less common areas of metastatic disease
include the dura mater, lung, and brain.2 Usually, if
intra-axial CNS involvement is seen, it is a result of an extension
from extra-axial lesions (eg, from the dura or
orbits).2,4-6 Isolated parenchymal disease is rare,
although the incidence has been rising with the introduction of
improved chemotherapeutic regimens and observed prolonged survival
rates.2,5
The patient in this case demonstrated the classic radiographic
findings of metastatic CNS disease, which was originally
exclusively in the extra-axial compartment and manifested as
extensive dural metastases. On the subsequent head CT, the expected
findings of progressive disease were shown with increased dural
metastastic bulk, intra-axial extension with cerebral and
intraventricular hemorrhage, and orbital metastases that caused
proptosis. The impressive sutural diastases were sequelae of the
growing dural metastases that exerted progressively increasing
pressure at the suture line.5 If this feature is seen on
imaging, the differential diagnosis is short and includes
metastatic neuroblastoma, leukemia, and lymphoma.1
Survival rates depend on the staging of disease. Stage I tumors
are limited to the organ of disease without metastases. Stage II
tumors have spread locally but have not crossed the midline. Stage
III tumors have extended across the midline. Stage IV tumors show
evidence of distant metastatic disease. A special subset of stage
IV has been designated as stage IVS, which has distant metastases
to the liver, skin, and bone marrow, without evidence of skeletal
metastases in children younger than 1 year. Stage IVS infers a much
better prognosis, similar to that of stage I
disease.5
CONCLUSION
Neuroblastoma CNS metastates are not uncommon to the dura or
orbits. Common CT manifestations include dural infiltration of the
disease, which may lead to sutural diastasis. When this finding is
present, the differential includes metastatic neuroblastoma,
lymphoma, and leukemia. Orbital metastatic disease usually presents
as a mass in the extraconal space with resultant proptosis. If
intra-axial extension occurs, hemorrhage is often present within
the tumor. CNS metastatic disease is stage IV neuroblastoma, which
infers a poor prognosis.
- Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma,
ganglioneuroblastoma, and ganglioneuroma: Radiologic-pathologic
correlation. RadioGraphics. 2002;22:911-934.
- Astigarraga I, Lejarreta R, Navajas A. Secondary central
nervous system metastases in children with neuroblastoma. Med
Pediatr Oncol.1996;27:529-533.
- Rha SE, Byun JY, Jung SE, et al. Neurogenic tumors in the
abdomen: Tumor types and imaging characteristics.
RadioGraphics.2003;23:29-43.
- Gallet BL, Egelhoff JC. Unusual CNS and orbital metastases of
neuroblastoma. Pediatr Radiol.1989;19:287-289.
- Zimmerman RA, Bilaniuk LT. CT of primary and secondary
craniocerebral neuroblastoma. AJR Am J
Roentgenol.1980;135:1239-1242.
- Koizumi JH, Dal Canto MC. Retroperitoneal neuroblastoma
metastatic to brain. Report of a case and review of the literature.
Childs Brain. 1980;7:267-279.